The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology
Cite this article
Ameya, K.P., Sekar, D. The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
Med Oncol 41, 308 (2024). https://doi.org/10.1007/s12032-024-02555-7
Download citation
Received: 29 October 2024
Accepted: 01 November 2024
Published: 06 November 2024
DOI: https://doi.org/10.1007/s12032-024-02555-7
Share this article
Anyone you share the following link with will be able to read this content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Comments (0)